Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
JBIO compared with ELVN: revenue, margins and what each company keeps, and the suppliers and customers both name
JBIO
Jade Biosciences, Inc.
Change
Mkt cap
Revenue
Revenue
ELVN
Enliven Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
JBIO
Jade Biosciences, Inc.
vs
ELVN
Enliven Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
Co-movers
daily closes
Method
›
Moved together
JBIO
with
ELVN
Uncorrelated: r 0.24 · 499D.
Shared co-movers
3
with JBIO
with ELVN
XNCR
Xencor Inc
r 0.29
r 0.35
IMNM
Immunome Inc.
r 0.28
r 0.33
SYRE
Spyre Therapeutics, Inc.
r 0.27
r 0.34
JBIO, solid
ELVN, hatched
r = correlation
Bar = r to r 0.75
Order: weaker of A and B
Source: daily closes
JBIO
Jade Biosciences, Inc.
Change
14.07
· pre 14.07
· delayed
Mkt cap
$894.2M
ELVN
Enliven Therapeutics, Inc.
Change
44.25
· pre 44.25
· delayed
Pre-market
Oct 30 '26
delayed
Mkt cap
$3.2B
vs
Compare
Pre-market
Oct 30 '26
delayed
JBIO
Jade Biosciences, Inc.
vs
ELVN
Enliven Therapeutics, Inc.
14.07
pre 14.07
delayed
Price
44.25
pre 44.25
delayed
$894.2M
Mkt cap
$3.2B
Change
Change
JBIO
14.07
vs
ELVN
44.25
Pre-market
Oct 30 '26
delayed